drugset

drugset / Trial / NCT00947063

To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions

NCT00947063 ↗

Phase 1 Completed 36 enrolled Sandoz

RandomizedCrossoverOpen-labelTreatment

Summary

To demonstrate the relative bioavailability study of Promethazine HCl 50 mg tablets under fasting conditions.

Timeline

Start: 2004-07
Primary completion: 2004-08
Completion: 2004-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Promethazine	Small molecule	50 mg	—

Indications